Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Expert Rev Vaccines. 2015 Mar 31;14(6):815–831. doi: 10.1586/14760584.2015.1027690

Figure 2.

Figure 2

N-glycopeptide fragments derived from gp120331–335 bearing (a) high-mannose and (b) hybrid-type glycans. (c) Total synthesis of Man9GlcNAc2 glycan using the convergent “block approach”.